Source-backed overview
Lung cancer: source-backed overview
A high-priority next cancer area because treatment conversations often depend on subtype, stage, biomarkers, and clinical trial timing.
Early signalsolid-tumorlast checked 2026-05-21
What this page does
Organizes the starting point
It helps organize diagnosis wording, stage, test results, specialists, and trial-search terms.
What it does not do
Does not choose treatment
It does not rank treatments, recommend a choice, or decide clinical fit.
Next build step
Verify before depth
Add subtype and biomarker records only after citations and claim-audit entries are ready.
Why this cancer is included
- Families often need to separate non-small cell lung cancer, small cell lung cancer, stage, and biomarker testing.
- The first MatchMedi version should help users gather the right report details before a lung oncology visit.
- A full lung module should wait until source mapping covers biomarkers and country-specific access.
Information to gather before the next visit
- Is the diagnosis non-small cell lung cancer, small cell lung cancer, or another subtype?
- What stage is documented, and is the cancer resectable?
- Which biomarker tests were ordered or completed?
- Did the oncologist mention immunotherapy, targeted therapy, chemotherapy, radiation, surgery, or trials?
Trial-search terms to discuss
This is an overview/navigation page, not a full treatment module. Deep records will be added only when source mapping, claim audit, and review workflow are ready.